Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome.

Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome.

Publication date: Aug 01, 2025

Fatigue is the most common symptom of Long COVID (LC), defined by persistent or newly emerging symptoms that develop at least three months after an initial SARS-CoV-2 infection, in the absence of other identifiable cause. This study investigates the prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as a potential comorbidity of LC. The study enrolled 37 adult controls with no documented SARS-CoV-2 infection and 32 individuals with a history of infection, categorized as LC-yes (with LC symptoms) and LC-no (without LC symptoms). ME/CFS diagnosis was based on the International Consensus Criteria (ICC). Among LC-yes cases, the most frequently reported symptoms included post-exertional malaise (PEM); neurosensory, perceptual, or motor disturbances; cognitive impairment; sleep disturbances; pain; impaired thermoregulation; and flu-like symptoms, all occurring significantly more than in the LC-no or control groups. All individuals in the LC-yes group reported PEM. ME/CFS was diagnosed in three LC-yes cases (18. 8%), one LC-no case (6. 7%), and four control subjects (10. 8%), with no statistically significant differences observed among groups. Experiencing more than six symptoms during acute infection, such as fatigue, loss of taste or smell, headache, fever, cough, myalgia, sore throat, shortness of breath, rhinorrhea, and diarrhea, was associated with a twofold higher risk of developing LC. A substantial proportion of LC-yes individuals experienced PEM; neurosensory, perceptual, or motor disturbances; cognitive impairment; and sleep disturbances, with rates significantly exceeding those in the LC-no and control groups. Nevertheless, only a minority of LC-yes cases (18. 8%) satisfied criteria for the ME/CFS, and the prevalence did not significantly differ from LC-no and controls. These findings suggest that while many symptoms of LC overlap with those of ME/CFS, only a subset of LC cases meet established ME/CFS diagnostic criteria.

Open Access PDF

Concepts Keywords
Encephalomyelitis chronic fatigue syndrome
Fatigue fatigue
Flu long covid
Icc myalgic encephalomyelitis
Months sars-cov-2

Semantics

Type Source Name
disease MESH Long COVID
disease MESH Chronic Fatigue Syndrome
disease IDO symptom
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH comorbidity
disease IDO history
disease MESH infection
disease MESH cognitive impairment
disease IDO acute infection
disease MESH loss of taste
disease MESH sore throat
disease MESH shortness of breath
pathway REACTOME Reproduction
drug DRUGBANK Ribostamycin
disease MESH pneumonia
disease MESH severe acute respiratory syndrome
disease MESH depression
disease MESH syndrome
disease MESH brain fog
disease MESH polyarthralgia
disease MESH viral infections
disease MESH neuromuscular diseases
disease MESH chronic kidney disease
disease IDO susceptibility
disease IDO production
disease MESH relapse
disease MESH symptom exacerbation
disease MESH emotional exhaustion
disease MESH symptom burden
disease MESH adjustment disorders
disease MESH anosmia
disease MESH memory loss
disease MESH confusion
disease MESH abnormalities
disease MESH inflammatory myopathy
disease MESH dysphagia
disease MESH peripheral neuropathy
disease MESH small fiber neuropathy

Original Article

(Visited 13 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *